CVS Health Co. (NYSE:CVS) Given Consensus Rating of “Buy” by Brokerages

Shares of CVS Health Co. (NYSE:CVSGet Rating) have been assigned a consensus recommendation of “Buy” from the twenty-five research firms that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $113.09.

Several analysts have weighed in on CVS shares. Deutsche Bank Aktiengesellschaft cut shares of CVS Health from a “buy” rating to a “hold” rating and set a $110.00 price objective on the stock. in a research note on Tuesday, March 29th. Truist Financial upped their price objective on shares of CVS Health from $118.00 to $124.00 and gave the stock a “buy” rating in a research note on Wednesday, January 5th. Robert W. Baird upped their price objective on shares of CVS Health from $107.00 to $110.00 in a research note on Wednesday, January 12th. Sanford C. Bernstein upped their price objective on shares of CVS Health from $111.00 to $116.00 in a research note on Tuesday, January 11th. Finally, BMO Capital Markets upped their price objective on shares of CVS Health from $108.00 to $120.00 in a research note on Thursday, February 10th.

In other news, Director Edward J. Ludwig bought 1,000 shares of the business’s stock in a transaction on Thursday, February 10th. The shares were bought at an average cost of $105.90 per share, for a total transaction of $105,900.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Jonathan C. Roberts sold 68,482 shares of the stock in a transaction on Thursday, January 27th. The stock was sold at an average price of $107.50, for a total transaction of $7,361,815.00. The disclosure for this sale can be found here. Insiders sold 226,147 shares of company stock worth $23,949,067 over the last 90 days. 0.69% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Transform Wealth LLC raised its holdings in CVS Health by 2.2% in the first quarter. Transform Wealth LLC now owns 105,956 shares of the pharmacy operator’s stock worth $10,724,000 after purchasing an additional 2,318 shares during the period. Welch & Forbes LLC increased its position in shares of CVS Health by 10.9% during the first quarter. Welch & Forbes LLC now owns 128,691 shares of the pharmacy operator’s stock worth $13,024,000 after acquiring an additional 12,615 shares in the last quarter. Mission Wealth Management LP increased its position in shares of CVS Health by 5.2% during the first quarter. Mission Wealth Management LP now owns 4,104 shares of the pharmacy operator’s stock worth $416,000 after acquiring an additional 204 shares in the last quarter. Assenagon Asset Management S.A. increased its position in shares of CVS Health by 117.7% during the first quarter. Assenagon Asset Management S.A. now owns 30,124 shares of the pharmacy operator’s stock worth $3,049,000 after acquiring an additional 16,289 shares in the last quarter. Finally, Allworth Financial LP increased its position in shares of CVS Health by 9.0% during the first quarter. Allworth Financial LP now owns 22,742 shares of the pharmacy operator’s stock worth $2,302,000 after acquiring an additional 1,884 shares in the last quarter. Institutional investors own 76.18% of the company’s stock.

NYSE CVS opened at $101.68 on Monday. The stock has a market cap of $133.53 billion, a P/E ratio of 17.06, a PEG ratio of 1.58 and a beta of 0.80. The company’s 50-day simple moving average is $104.25 and its 200 day simple moving average is $99.80. CVS Health has a twelve month low of $74.97 and a twelve month high of $111.25. The company has a quick ratio of 0.62, a current ratio of 0.88 and a debt-to-equity ratio of 0.69.

CVS Health (NYSE:CVSGet Rating) last posted its earnings results on Wednesday, February 9th. The pharmacy operator reported $1.98 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.94 by $0.04. The business had revenue of $76.60 billion for the quarter, compared to analysts’ expectations of $76.01 billion. CVS Health had a net margin of 2.71% and a return on equity of 15.15%. During the same quarter in the previous year, the firm posted $1.30 earnings per share. Research analysts anticipate that CVS Health will post 8.23 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, May 2nd. Investors of record on Friday, April 22nd will be issued a $0.55 dividend. The ex-dividend date of this dividend is Thursday, April 21st. This represents a $2.20 annualized dividend and a yield of 2.16%. CVS Health’s dividend payout ratio is currently 36.91%.

About CVS Health (Get Rating)

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.

Featured Articles

Analyst Recommendations for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.